company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1134859.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1134859.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1134859.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3027593.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3083229.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6110822.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4975963.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-13594.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3327758.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3314164.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8290127.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,676179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7613948.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7613948.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2490.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7616438.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102811417.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:10:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1276543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1276543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1276543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2881994.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2951067.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5833061.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4556518.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-14714.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2604311.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2619025.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1937493.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,522760.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1414733.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1414733.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4585.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1410148.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102928096.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 06:30:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3105265.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3105265.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3105265.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3319232.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4421799.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-250000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7491031.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4385766.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1963712.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1963712.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2422054.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2422054.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2422054.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9441.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2412613.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120600000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120600000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120922577.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 17:11:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2419763.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2419763.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2419763.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3092386.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4463978.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7556364.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5136601.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2299330.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2299330.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2837271.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2837271.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2837271.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15112.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2822159.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127256364.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:06:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2637561.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2637561.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2637561.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2323188.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6987824.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-337000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8974012.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6336451.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1779870.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1779870.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4556581.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4556581.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4556581.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14649.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4541932.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127256907.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:41:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1632668.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1632668.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1632668.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3253990.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4158400.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7412390.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5779722.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,291533.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,291533.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5488189.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5488189.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5488189.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11948.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5476241.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126239336.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1693121.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1693121.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1693121.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2488088.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4042579.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-651000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5879667.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4186546.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4078173.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4078173.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8264719.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8264719.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8264719.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9770.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8254949.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137600000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137600000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134968394.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:26:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,436082.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,436082.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,436082.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2696909.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4527086.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7223995.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6787913.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2643445.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2643445.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4144468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4144468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4144468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11289.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4133179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134968394.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:24:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,854696.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,854696.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,854696.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2674362.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4972319.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7146681.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6291985.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-340504.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-340504.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6632489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6632489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6632489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10413.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6622076.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135389308.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 06:08:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1134753.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1134753.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1134753.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2919000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4442841.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7361841.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6227088.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5555784.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5555784.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-671304.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-671304.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-671304.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12553.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-658751.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34127312.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34127312.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1455225.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1455225.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1455225.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2974153.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5115112.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8089265.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6634040.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2224240.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2224240.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8858280.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8858280.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8858280.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14160.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8844120.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,147400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,147400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156155532.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 18:13:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,785610.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,785610.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,785610.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3046586.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4411082.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6457668.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5672058.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5194538.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5194538.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10866596.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10866596.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10866596.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14008.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10852588.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44988704.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44988704.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:46:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9486845.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9486845.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9486845.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3282796.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5438405.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8721201.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,765644.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31656497.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31656497.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30890853.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30890853.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30890853.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13443.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30877410.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47989039.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47989039.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48200000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 18:08:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1739666.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1739666.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1739666.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4339539.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6404005.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9743544.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8003878.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7463925.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7463925.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15467803.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15467803.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15467803.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13473.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15454330.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46087773.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46087773.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46200000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2357643.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2357643.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2357643.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4132218.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8225480.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12357698.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10000055.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-830813.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-830813.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10830868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10830868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10830868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9408.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10821460.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55159002.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55159002.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:51:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3801662.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3801662.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3801662.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4347327.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9607281.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13954608.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10152946.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-564771.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-564771.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10717717.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10717717.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10717717.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6443.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10711274.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60232498.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60474859.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 18:31:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1840353.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1840353.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1840353.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3153714.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7017805.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10171519.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8331166.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1152105.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1152105.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7179061.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7179061.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7179061.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1486.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7177575.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60392911.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60602831.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 20:00:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2457108.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2457108.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2457108.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4224429.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9244473.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13468902.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11011794.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3599307.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3599307.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7412487.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7412487.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7412487.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1083.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7411404.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59127349.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59408252.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59200000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5166637.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5166637.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5166637.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4107928.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9426320.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13534248.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8367611.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2215260.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2215260.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10582871.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10582871.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10582871.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1092.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10581779.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60741082.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60913423.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62200000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:47:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5286678.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5286678.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5286678.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4718260.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16688511.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20406771.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15120093.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8957704.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8957704.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6162389.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6162389.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6162389.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,85861.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6248250.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67655975.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67838738.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 18:00:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24183234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24183234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24183234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4377616.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16075201.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20452817.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3730417.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,74805.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,74805.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3805222.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1789246.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5594468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5594468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5594468.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72029644.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73961237.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:07:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5935562.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5935562.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5935562.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4860086.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15601891.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20461977.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14526415.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3734150.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3734150.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18260565.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-308520.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17952045.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17952045.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17952045.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68198142.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68365265.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8110155.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8110155.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8110155.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5371613.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18189160.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23560773.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15450618.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7407798.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7407798.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8042820.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8042820.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8042820.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8042820.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72230411.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72230411.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 15:41:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6203791.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6203791.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6203791.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5799530.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19630801.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24430331.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18226540.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-478171.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-478171.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18704711.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18704711.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18704711.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18704711.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72957159.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 15:48:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12540463.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12540463.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12540463.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5755603.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26980343.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32735946.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20195483.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-563855.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-563855.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20759338.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20759338.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20759338.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20759338.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73602834.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73789008.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:56:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8513952.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8513952.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8513952.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6965517.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23911731.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30877248.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22363296.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3870174.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3870174.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26233470.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26233470.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26233470.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26233470.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73214766.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73214766.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10376185.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10376185.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10376185.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7767589.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24542504.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32310093.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21933908.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1151999.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1151999.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23085907.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23085907.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23085907.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23085907.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74152609.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74300884.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 15:47:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20412124.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20412124.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20412124.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6169106.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23878751.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30047857.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9635733.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,156617.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,156617.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9479116.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9479116.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9479116.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9479116.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75409702.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75409702.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:51:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2644543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2644543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2644543.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6319775.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25510239.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31830014.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29185471.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4949099.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4949099.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34134570.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34134570.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34134570.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34134570.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86952024.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87090683.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87500000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:57:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8787234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8787234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8787234.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8033899.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24641124.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31675023.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22887789.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25933.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1605087.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-197544.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1381610.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21506179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21506179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21506179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21506179.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81777493.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81918022.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81700000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1529644.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1529644.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1529644.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9698015.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24577751.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34275766.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32746122.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-312523.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2252582.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2565105.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30181017.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2169811.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32350828.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32350828.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32350828.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89900000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90451791.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:00:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24448761.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24448761.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24448761.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7189310.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22462620.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29651930.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5203169.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1314112.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-121844.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1435956.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6639125.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6639125.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6639125.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6639125.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91153776.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91241660.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94800000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 15:51:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2000868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2000868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2000868.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6791693.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21851858.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28643551.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26642683.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1811063.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-184052.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1627011.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25015672.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25015672.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25015672.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25015672.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92423122.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92423122.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92700000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2502624.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2502624.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2502624.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5636141.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26365647.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32001788.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29499164.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,312523.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2112558.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1037960.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3463041.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32962205.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,189.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32962394.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32962205.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32962205.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92539997.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92539997.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2829905.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2829905.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2829905.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6975029.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24389888.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31364917.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28535012.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,656248.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-124568.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35839.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-816655.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29351667.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-62800.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29288867.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29288867.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-69605.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29219262.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97494968.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 15:58:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,135673.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,135673.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135673.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5850101.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22486266.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28336367.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28200694.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2194783.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,582118.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1612665.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29685847.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-106771.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,127512.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29451564.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29579076.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-191850.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29387226.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98083896.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98083896.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98000000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 15:51:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,866863.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,866863.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,866863.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5681441.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19137209.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24818650.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23951787.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2428671.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,151597.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2692409.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,415335.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23536452.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23536452.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23536452.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-445759.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23090693.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99007985.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102807056.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100400000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,279489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,279489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279489.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8696585.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22003956.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30700541.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30421052.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2668837.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1093723.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3924022.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7686582.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38235146.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-130429.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-127512.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38232229.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38147382.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-485344.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37662038.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98717999.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98717999.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98600000.0
Inovio Pharmaceuticals Inc,INO,,0001055726,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
